{"id":"https://openalex.org/W2036655406","doi":"https://doi.org/10.1097/ftd.0b013e3181c4cebb","title":"Comparison of a New Serum Topiramate Immunoassay to Fluorescence Polarization Immunoassay","display_name":"Comparison of a New Serum Topiramate Immunoassay to Fluorescence Polarization Immunoassay","publication_year":2010,"publication_date":"2010-01-22","ids":{"openalex":"https://openalex.org/W2036655406","doi":"https://doi.org/10.1097/ftd.0b013e3181c4cebb","mag":"2036655406","pmid":"https://pubmed.ncbi.nlm.nih.gov/20010458"},"language":"en","primary_location":{"id":"doi:10.1097/ftd.0b013e3181c4cebb","doi":"https://doi.org/10.1097/ftd.0b013e3181c4cebb","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0b013e3181c4cebb","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032369305","display_name":"Christine L.H. Snozek","orcid":"https://orcid.org/0000-0003-0769-7165","observed_orcids":["https://orcid.org/0000-0003-0769-7165"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christine L H Snozek","raw_affiliation_strings":["Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. snozek.christine@mayo.edu","Christine L. H. Snozek, PhD, Hilton 730, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905 (e-mail: [email\u00a0protected])","Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. snozek.christine@mayo.edu","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Christine L. H. Snozek, PhD, Hilton 730, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905 (e-mail: [email\u00a0protected])","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111774612","display_name":"Lisa A. Rollins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa A Rollins","raw_affiliation_strings":["Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paul W Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul W Peterson","raw_affiliation_strings":["Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089457416","display_name":"Loralie J. Langman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Loralie J Langman","raw_affiliation_strings":["Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reagents for the ARK immunoassay were provided free of charge and costs associated with the ARK immunoassay were funded by ARK Diagnostics. The remainder of the study was supported by Mayo Clinic internal funds","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"the Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032369305"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":0.8995,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.73141579,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"1","first_page":"107","last_page":"111"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.1770000010728836,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.07370000332593918,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.6639999747276306},{"id":"https://openalex.org/keywords/immunoassay-comparison","display_name":"immunoassay comparison","score":0.8420000076293945},{"id":"https://openalex.org/keywords/fluorescence-polarization-immunoassay","display_name":"fluorescence polarization immunoassay","score":0.996999979019165},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9639999866485596},{"id":"https://openalex.org/keywords/analytical-performance","display_name":"analytical performance","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C2778060338","wikidata":"https://www.wikidata.org/wiki/Q30314615","display_name":"Fluorescence polarization immunoassay","level":2,"score":0.8922905325889587},{"id":"https://openalex.org/C2780420688","wikidata":"https://www.wikidata.org/wiki/Q759183","display_name":"Immunoassay","level":3,"score":0.8706373572349548},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.781936526298523},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.594730794429779},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.590935468673706},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5199759602546692},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4266747832298279},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.4188721776008606},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38078683614730835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3236919641494751},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.22602733969688416},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.143991619348526},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1386888027191162},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.07041603326797485},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.05122494697570801}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007118","descriptor_name":"Immunoassay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016231","descriptor_name":"Fluorescence Polarization Immunoassay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/ftd.0b013e3181c4cebb","doi":"https://doi.org/10.1097/ftd.0b013e3181c4cebb","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0b013e3181c4cebb","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:20010458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20010458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Comparative Study"},{"id":"mag:2407745268","doi":null,"is_oa":false,"landing_page_url":"http://www.temaricerca.com/entry2013new/diagnostica/laboratorio_ricerca_diagnostica_download/risorse_diagnostica/tema_ricerca_support_11.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306143","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1967212780","https://openalex.org/W1983615883","https://openalex.org/W2024074840","https://openalex.org/W2060587811"],"related_works":["https://openalex.org/W1983615883","https://openalex.org/W2025349244","https://openalex.org/W2146135444","https://openalex.org/W1993519592","https://openalex.org/W2115265220","https://openalex.org/W620432519","https://openalex.org/W2029606925","https://openalex.org/W2407242783","https://openalex.org/W2017552339","https://openalex.org/W2047621410"],"abstract_inverted_index":{"Topiramate":[0],"is":[1,164],"a":[2,56],"newer":[3],"anticonvulsant":[4],"used":[5],"to":[6,22,82,108,152,159],"treat":[7],"epilepsy,":[8],"migraines,":[9],"bipolar":[10],"disorder,":[11],"posttraumatic":[12],"stress,":[13],"and":[14,32,55,77,157],"other":[15],"conditions.":[16],"Serum":[17],"topiramate":[18,40,115],"concentrations":[19,116,131],"are":[20],"measured":[21],"determine":[23],"optimal":[24],"levels,":[25],"address":[26],"therapeutic":[27,119],"failure":[28],"or":[29],"drug-drug":[30],"interactions,":[31],"assess":[33],"compliance.":[34],"Two":[35],"high-throughput":[36,167],"assays":[37],"for":[38,85],"serum":[39,114],"measurement":[41],"were":[42,80,91],"compared:":[43],"the":[44,86,118,148,162],"Seradyn":[45],"fluorescence":[46],"polarization":[47],"immunoassay":[48,58,105,138,150],"(FPIA)":[49],"on":[50,63,141],"an":[51,64],"Abbott":[52],"TDx/FLx":[53],"instrument":[54],"new":[57],"from":[59],"ARK":[60,87,104,137,149],"Diagnostics":[61],"performed":[62,106],"Olympus":[65],"AU680":[66],"automated":[67],"analyzer.":[68],"Precision,":[69],"linearity,":[70],"limit":[71],"of":[72,95],"quantitation,":[73],"carryover,":[74],"spike":[75],"recovery,":[76],"endogenous":[78],"interferences":[79],"found":[81],"be":[83],"acceptable":[84,154],"assay.":[88],"These":[89],"studies":[90],"complemented":[92],"by":[93],"comparison":[94],"120":[96],"patient":[97],"samples":[98],"analyzed":[99],"using":[100],"both":[101],"methods.":[102],"The":[103],"comparably":[107],"FPIA":[109],"with":[110,136,166],"minimal":[111],"difference":[112],"in":[113],"within":[117],"range":[120],"(2.0-20":[121],"microg/mL).":[122],"A":[123],"slight":[124],"systematic":[125],"discordance":[126],"was":[127],"observed":[128],"at":[129],"higher":[130,144],"(greater":[132],"than":[133,145],"30":[134],"microg/mL)":[135],"results":[139],"being":[140],"average":[142],"6%":[143],"FPIA.":[146],"Thus,":[147],"appears":[151],"provide":[153],"analytical":[155],"performance":[156],"comparability":[158],"FPIA;":[160],"furthermore,":[161],"assay":[163],"compatible":[165],"autoanalyzers.":[168]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}